Peripheral oxytocin administration reduces ethanol consumption in rats

Area of Science:

• Neuroscience
• Behavioral Pharmacology
• Addiction Research

Background:

• Oxytocin is a neuropeptide involved in reward pathways, including those related to filial behaviors, eating, and substance abuse.
• Previous research suggests oxytocin may decrease the intake of abused substances, leading to its investigation as a potential alcoholism treatment.

Purpose of the Study:

• To investigate the efficacy of oxytocin in reducing ethanol consumption in male Sprague-Dawley rats.
• To compare the effects of oxytocin on ethanol intake versus general caloric intake.

Main Methods:

• Two ethanol self-administration paradigms were employed: a three-bottle choice model and an operant conditioning model.
• Rats were administered varying doses of oxytocin (0.05-0.5 mg/kg) or saline via intraperitoneal injection.
• Ethanol intake was measured in the three-bottle choice study, and consumption of ethanol gelatin versus plain gelatin was assessed in the operant study.

Main Results:

• Oxytocin administration significantly decreased ethanol intake in the three-bottle choice study at doses of 0.1, 0.3, and 0.5 mg/kg.
• In the operant study, 0.3 mg/kg oxytocin reduced ethanol gelatin consumption more than plain gelatin consumption, affecting both amount and caloric intake.
• These results indicate oxytocin specifically targets ethanol intake, not just general caloric intake.

Conclusions:

• Oxytocin demonstrates significant efficacy in reducing ethanol intake in rat models.
• The findings corroborate clinical studies suggesting oxytocin's potential as a therapeutic intervention for alcoholism.